A publicly traded company positioned as a major ETH corporate treasury play.
AI-generated insights about Bitmine Immersion from various financial sources
ARKK ETF bought a significant number of shares, indicating conviction from ARK Invest.
Amit (@amitisinvesting) believes the Kerrisdale short report is exceptionally poor, suggesting a potential opportunity for investors to re-evaluate the short thesis as the market may have overreacted.
A stock to avoid due to its risky strategy of selling its own shares to buy Ethereum, exposing investors to significant shareholder dilution and high dependency on the volatile price of ETH.
User is bullish on this asset. A position is shown with a total return of +25.46%, indicating a strengthening long-term thesis despite potential volatility.
A user associated with Syncracy Capital and Messari is requesting a HIP-3 market for BMNR perps, indicating they see value in this offering and potential trading interest.
Extremely volatile stock that is trading far above its recent $4 financing price. A significant price drop is anticipated due to a pending dilution event from a 45-day lockup on cheap shares. The recommended strategy is to wait for this drop.
ARKK ETF bought a significant number of shares, indicating conviction from ARK Invest.
Amit (@amitisinvesting) believes the Kerrisdale short report is exceptionally poor, suggesting a potential opportunity for investors to re-evaluate the short thesis as the market may have overreacted.
A stock to avoid due to its risky strategy of selling its own shares to buy Ethereum, exposing investors to significant shareholder dilution and high dependency on the volatile price of ETH.
User is bullish on this asset. A position is shown with a total return of +25.46%, indicating a strengthening long-term thesis despite potential volatility.
A user associated with Syncracy Capital and Messari is requesting a HIP-3 market for BMNR perps, indicating they see value in this offering and potential trading interest.
Extremely volatile stock that is trading far above its recent $4 financing price. A significant price drop is anticipated due to a pending dilution event from a 45-day lockup on cheap shares. The recommended strategy is to wait for this drop.